z-logo
Premium
A Photosensitive Polymeric Carrier with a Renewable Singlet Oxygen Reservoir Regulated by Two NIR Beams for Enhanced Antitumor Phototherapy
Author(s) -
Yang Chun,
Su Meihui,
Luo Pei,
Liu Yanan,
Yang Feng,
Li Changhua
Publication year - 2021
Publication title -
small
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.785
H-Index - 236
eISSN - 1613-6829
pISSN - 1613-6810
DOI - 10.1002/smll.202101180
Subject(s) - singlet oxygen , photosensitizer , photodynamic therapy , photothermal therapy , photochemistry , oxygen , materials science , laser , irradiation , chemistry , optoelectronics , nanotechnology , optics , organic chemistry , physics , nuclear physics
Photodynamic therapy (PDT), which utilizes photosensitizer to convert molecular oxygen into singlet oxygen ( 1 O 2 ) upon laser irradiation to ablate tumors, will exacerbate the already oxygen shortage of most solid tumors and is thus self‐limiting. Herein, a sophisticated photosensitive polymeric material (An‐NP) that allows sustained 1 O 2 generation and sufficient oxygen supply during the entire phototherapy is engineered by alternatively applying PDT and photothermal therapy (PTT) controlled by two NIR laser beams. In addition to a photosensitizer that generates 1 O 2 , An‐NP consists of two other key components: a molecularly designed anthracene derivative capable of trapping/releasing 1 O 2 with superior reversibility and a dye J‐aggregate with superb photothermal performance. Thus, in 655 nm laser‐triggered PDT process, An‐NP generates abundant 1 O 2 with extra 1 O 2 being trapped via the conversion into EPO‐NP; while in the subsequent 785 nm laser‐driven PTT process, the converted EPO‐NP undergoes thermolysis to liberate the captured 1 O 2 and regenerates An‐NP. The intratumoral oxygen level can be replenished during the PTT cycle for the next round of PDT to generate 1 O 2 . The working principle and phototherapy efficacy are preliminarily demonstrated in living cells and tumor‐bearing mice, respectively.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here